05:00
2026-07-08
innolitics.com
artificial-intelligence
Q2 2026 AI/ML FDA Clearances and De Novos
The FDA cleared 14 AI/ML-enabled medical devices in Q2 2026, including De Novos and 510(k)s, spanning neurology, cardiology, radiology, and other specialties. Key clearances include neuropacs' MSAp/PSโฆ